Welcome to our dedicated page for Runway Growth Finance news (Ticker: RWAY), a resource for investors and traders seeking the latest updates and insights on Runway Growth Finance stock.
Runway Growth Finance Corp. (Nasdaq: RWAY) is a specialty finance company that focuses on providing flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity. As a business development company regulated under the Investment Company Act of 1940 and externally managed by Runway Growth Capital LLC, the firm regularly issues detailed updates on its investment portfolio, financial performance, and strategic initiatives.
This news page aggregates Runway Growth Finance’s public announcements, including quarterly financial results, portfolio and transaction updates, dividend declarations, and information about significant corporate actions. Recent releases have covered topics such as investment income, net asset value, leverage, new originations and follow-on investments, as well as liquidity events like loan repayments and equity realizations across technology, healthcare, and select consumer services and products industries.
Investors and analysts following RWAY can use this feed to monitor developments such as the company’s planned acquisition of SWK Holdings Corporation, a life science focused specialty finance company, and its integration within the BC Partners Credit platform. The news also highlights Runway Growth Finance’s approach to portfolio construction, its emphasis on senior secured loans, and its stated objective of offering an alternative to equity financing for late- and growth-stage businesses.
By reviewing the historical and ongoing news items on this page, readers can track how Runway Growth Finance manages its portfolio, declares and pays dividends, and pursues strategic transactions. Returning to this page provides a centralized view of RWAY’s press releases and related disclosures over time.
Runway Growth Finance (Nasdaq: RWAY) reported a fourth-quarter 2025 portfolio and transaction update. During Q4 the company funded $42.9 million across seven investments, including a $20.0M mobility deal, a $10.0M SPV commitment, and a $20.0M Shield Therapeutics facility (with $2.0M funded at close); follow-ons totaled $10.9M. Q4 liquidity events totaled $77.8M, driven by principal repayments from Synack ($45.0M) and Dejero Labs ($14.7M), an assignment of $15.0M in Kin Insurance, plus other repayments.
The pending acquisition of SWK Holdings is expected to close late Q1 2026 pending regulatory approvals; Runway filed a Form N-14 on Nov 18, 2025. As of Dec 31, 2025 the portfolio included 40 debt investments to 31 companies and 72 equity investments in 48 companies, with 24 companies holding both debt and equity positions.
Runway Growth Capital (NASDAQ: RWAY) announced that Ryan McCarthy joined the firm as Managing Director on Dec. 10, 2025. McCarthy will focus on sourcing, evaluating, and structuring growth loan opportunities across the technology and life sciences markets while deepening relationships with founders, management teams, and financial sponsors.
He brings nearly two decades of experience in venture debt, debt advisory, and investment banking, most recently as Managing Director at Capital Advisors Group, and previously at TriplePoint Capital, Headwaters MB, and Rutberg & Company. McCarthy holds an MBA and MSF from Boston College and a BA from Hamilton College and is based in Menlo Park.
Runway Growth Finance (Nasdaq: RWAY) reported third quarter 2025 results with total investment income $36.7M and net investment income $15.7M (or $0.43/share). Investment portfolio fair value $945.96M across 54 companies with a dollar-weighted annualized yield on debt investments of 16.8%. NAV $489.5M or $13.55/share (down 0.8% QoQ). Available liquidity totaled $371.9M and core leverage fell to ~92%. Company repurchased 397,983 shares for $4.4M and declared a $0.33/share dividend for Q4 2025. Post-quarter, Runway entered a merger agreement to acquire SWK Holdings to expand healthcare and life sciences exposure.
Runway Growth Finance Corp (Nasdaq: RWAY) announced a $0.33 per share cash distribution for the fourth quarter of 2025. Key dates: Declaration Date: November 5, 2025; Record Date: November 17, 2025; Payment Date: December 3, 2025.
The company said it generally intends to distribute substantially all available earnings on a quarterly basis, subject to Board discretion and conditions including the company’s earnings, financial condition, maintenance of regulated investment company status, and compliance with business development company regulations.
The company maintains an opt-out dividend reinvestment plan; stockholders not opted out will have cash dividends automatically reinvested in additional common shares.
Runway Growth Capital (NASDAQ:RWAY) was named to Inc. Magazine's 2025 Founder-Friendly Investors list for the third consecutive year, highlighting its focus on minimally dilutive growth loans that preserve founder ownership and control.
Key facts: Runway has partnered with >80 businesses and committed over $3.0 billion in loans since 2015. In January 2025 Runway was acquired by BC Partners Credit, aligning Runway with BC's $40 billion in assets under management while retaining its leadership team and credit culture.
Disclosure notes a paid entry fee for the award, which may create a conflict of interest.
Runway Growth Finance Corp (Nasdaq: RWAY) will release its Q3 2025 financial results after market close on Thursday, November 6, 2025.
The company will host a conference call and webcast the same day at 3:00 p.m. PT (6:00 p.m. ET). Participants are asked to register via the Runway Growth investor relations website, preferably a day before or at least 15 minutes before the call. A replay of the webcast will be available two hours after the call and archived on the same webpage for 90 days.
Runway Growth Finance (Nasdaq: RWAY) entered a definitive merger agreement to acquire SWK Holdings (Nasdaq: SWKH), a life‑science specialty finance firm, in an NAV‑for‑NAV transaction with an estimated purchase price of ~$220 million (including estimated transaction expenses).
Pro forma, the deal raises total assets to $1.3 billion, increases healthcare exposure to ~31% of the portfolio (from 14% as of 6/30/2025), and is expected to deliver mid‑single‑digit NII accretion in the first full quarter after close. Consideration includes $75.5 million in Runway Growth shares, ~$145 million in cash, and a $9 million adviser cash contribution. SWK’s portfolio (22 companies) has an approximate fair value of $242 million (est. 8/15/2025). The close is expected late 2025–Q1 2026, subject to approvals.
Runway Growth Finance (Nasdaq: RWAY) provided its quarter-ended September 30, 2025 portfolio update, reporting $128.3 million funded across 11 investments and $201.2 million of liquidity events during Q3 2025.
Key deployments included new financings to Digicert ($9.3M funded), FHAS ($7.5M funded), and full refinancings for Kin ($45.0M), Madison Reed ($40.0M), and Skillshare ($12.9M). Liquidity receipts included full principal repayments from Kin ($75.0M), Interactions ($40.0M), FiscalNote ($25.8M), Nalu Medical ($21.1M), and others.
As of Sept 30, 2025 the portfolio comprised 47 debt investments across 30 companies and 89 equity investments across 47 companies.
Runway Growth Capital (NASDAQ:RWAY) and PitchBook have released their 2024-2025 Venture Debt Review, revealing significant shifts in the venture debt landscape. The report highlights that venture debt reached a record $53 billion in 2024, despite lower deal counts.
Key findings show that nearly 60% of venture debt financings occurred at late or venture-growth stages, and 67% of respondents focus on funding expansion-stage companies. The study reveals a significant perception shift, with 61% of respondents no longer viewing venture debt as "rescue financing". While exit value increased to $152.9B in 2024, IPO timelines are at their longest in over a decade, with over 1,300 companies valued at $500M+.
Runway Growth Finance Corp. (Nasdaq: RWAY), a provider of flexible capital solutions to late-stage companies, reported strong Q2 2025 financial results. The company delivered total investment income of $35.1 million and net investment income of $13.9 million ($0.38 per share).
Key highlights include a dollar-weighted annualized yield of 15.40% on debt investments, completion of $37.8 million in funded investments across three portfolio companies, and declaration of $0.36 per share in Q3 distributions. The investment portfolio reached $1.0 billion across 54 companies, with 97.8% in senior secured loans. Net asset value stood at $498.9 million ($13.66 per share), representing a 1% increase from the previous quarter.
The company maintains strong liquidity with $297.0 million available, including $6.0 million in cash and $291.0 million in credit facility capacity.
FAQ
What is the current stock price of Runway Growth Finance (RWAY)?
What is the market cap of Runway Growth Finance (RWAY)?
